Humanigen, Inc. (HGENQ)

Humanigen Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	1.7	2.51	3.6	0.31	0	0
Revenue Growth (YoY)	-59.01%	-30.07%	1052.24%	-	-	-
Gross Profit	1.7	2.51	3.6	0.31	0	0
Selling, General & Admin	14.98	15.61	23.25	15.8	6.33	9.11
Research & Development	38.73	55.21	213.12	72.71	2.62	2.22
Other Operating Expenses	0	0	0	0	0	0.15
Operating Expenses	53.71	70.82	236.37	88.51	8.94	11.48
Operating Income	-52.01	-68.3	-232.77	-88.2	-8.94	-11.48
Interest Expense / Income	2.2	2.92	2.26	1.34	1.35	0.85
Other Expense / Income	-0.58	-0.49	1.61	0	0	-0.32
Pretax Income	-53.63	-70.73	-236.65	-89.54	-10.29	-12
Net Income	-53.63	-70.73	-236.65	-89.54	-10.29	-12
Shares Outstanding (Basic)	119	89	59	37	22	19
Shares Outstanding (Diluted)	119	89	59	37	22	19
Shares Change	81.55%	52.45%	58.36%	65.30%	17.99%	532.75%
EPS (Basic)	-0.54	-0.79	-4.04	-2.42	-0.46	-0.65
EPS (Diluted)	-0.54	-0.79	-4.04	-2.42	-0.46	-0.65
Free Cash Flow	-64.32	-76.7	-184.05	-69.85	-4	-6.21
Free Cash Flow Per Share	-0.54	-0.86	-3.14	-1.89	-0.18	-0.33
Gross Margin	100.00%	100.00%	100.00%	100.00%	-	-
Operating Margin	-3061.21%	-2716.95%	-6474.88%	-28268.59%	-	-
Profit Margin	-3156.80%	-2813.44%	-6582.73%	-28697.12%	-	-
Free Cash Flow Margin	-3785.46%	-3050.84%	-5119.47%	-22388.46%	-	-
EBITDA	-51.43	-67.81	-234.39	-88.2	-8.95	-11.13
EBITDA Margin	-3027.19%	-2697.37%	-6519.75%	-28268.91%	-	-
Depreciation & Amortization	0	0	0	0	0	0.02
EBIT	-51.43	-67.81	-234.39	-88.2	-8.95	-11.15
EBIT Margin	-3027.19%	-2697.37%	-6519.75%	-28268.91%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).